Trial Profile
Clinical Trials Insight: 700043017
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 03 Apr 2009
Price :
$35
*
At a glance
- Drugs Palonosetron (Primary) ; Dexamethasone
- Indications Chemotherapy-induced nausea and vomiting
- Focus Therapeutic Use
- Sponsors Helsinn
- 20 Mar 2009 Results have been presented at European Society of Medical Oncology (ESMO) Symposium on Cancer and Nutrition.
- 20 Mar 2009 New trial record.